Latest C.R. Bard (BCR) Headlines
Why Endologix (ELGX) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:43AM CDT
It may be a good decision to sell Endologix as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a poor Zacks Rank confirms weakness.
Patterson Companies Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 5:15PM CDT
Patterson continues to face a challenging macro environment due to uncertainties surrounding the U.S. healthcare system as well as the ongoing austerity measures that have dampened demand for the past few years.
CR Bard Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:10AM CDT
Shares of BCR started escalating following optimism triggered by promising 2014 guidance.
Quest Diagnostics Ups View on Solstas Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 4:20PM CDT
With the declaration of the closure of its earlier announced acquisition of Solstas Lab Partners Group and its subsidiaries, Quest Diagnostics also raised its 2014 financial outlook.
DENTSPLY International Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:30PM CDT
Positive earnings guidance and anticipated improvement in the global market conditions in 2014, combined with improving leveraged position and margins, represent a potential upside for DENTSPLY going forward.
Watch for CR Bard to Potentially Pullback After Gaining 1.15% Yesterday
Comtex SmarTrend(R) - Mon Mar 10, 5:28PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $143.50 to a high of $145.86. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $145.55 on volume of 752,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CR Bard Rises 1.15% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Mar 10, 5:28PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $143.50 to a high of $145.86. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $145.55 on volume of 752,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Balanced View Continues for Henry Schein - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 1:50PM CDT
On Mar 07, 2014, we issued an updated research report on Henry Schein Inc.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cooper Companies Beats on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:32PM CST
For fiscal 2014, COO now expects total revenues between $ 1,685 and $1,725 million compared with the prior guidance of $1,675 and $1,735 million.
Financial Results Releases, Clinical Study Updates, Stock Summaries, and Strategic Agreements - Analyst Notes on Insmed, Medtronic, CR Bard, LabCorp, and Acceleron Pharma
PR Newswire - Fri Mar 07, 5:19AM CST
Today, Analysts Review released its analysts' notes regarding Insmed Incorporated (NASDAQ: INSM), Medtronic, Inc. (NYSE: MDT), CR Bard Inc. (NYSE: BCR), Laboratory Corp. of America Holdings (NYSE: LH), and Acceleron Pharma, Inc. (NASDAQ: XLRN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Bio-Reference Laboratories (BRLI) Falls: Stock Goes Down 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:42AM CST
Bio-Reference Laboratories saw a big move last session on pretty good volume with far more shares changing hands than in a normal session; shares fell over 5% on the day.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
Insider Trading Alert - BCR, ADS And PII Traded By Insiders
at The Street - Fri Feb 28, 9:45AM CST
Stocks with insider trader activity include BCR, ADS and PII
CR Bard Set to Possibly Pullback After Yesterday's Rally of 1.15%
Comtex SmarTrend(R) - Thu Feb 27, 5:08PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $142.68 to a high of $145.21. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $144.06 on volume of 824,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of CR Bard to Potentially Pullback after Yesterday's 1.15% Rise
Comtex SmarTrend(R) - Thu Feb 27, 5:07PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $142.68 to a high of $145.21. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $144.06 on volume of 824,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Insider Trading Alert - BCR, CBG And FANG Traded By Insiders
at The Street - Thu Feb 27, 9:45AM CST
Stocks with insider trader activity include BCR, CBG and FANG
Global Medical Electrodes Market Forecasts & Opportunities, 2018
M2 - Thu Feb 27, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/5hvqsv/global_medical) has announced the addition of the "Global Medical Electrodes Market Forecasts & Opportunities, 2018" report to their offering. Reusable electrodes present risks of cross contamination leading to hospital acquired infections. Commonly referred to as nosocomial infections, these infections affect about 1.7 million of the US population every year causing the death of roughly 99,000 people. Hence, medical device equipment employing electrodes needs to be replaced to avoid hospital acquired infections. Thus, the market is currently witnessing a shift toward increase in the use of disposable electrodes. These electrodes could be used for about a week or more before discarding them. They are cost effective and flexible for use in patients. This trend is in turn expected to drive the growth of the Global Medical Device Electrodes market. According to the report, one of the major drivers in this market is the increase in the aging population. The rising aging population is contributing toward an increase in usage of medical devices. This in turn is driving the growth of the Global Medical Device Electrodes market. Further, the report states that one of the main challenges in this market is pricing pressures. Fluctuations in the price of metals and by-products of petrol such as plastic could affect the price rate of the supplies within the supply chain. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Geographical Segmentation 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis - 3M Corp. - Ambu A/S - CR Bard Inc. - Covidien plc. - ConMED Corp. - Cardinal Health Inc. For more information visit http://www.researchandmarkets.com/research/5h...al_medical
Patterson Companies Q3 Meets Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:05AM CST
Revenues for the quarter grew 18.2% to $1,082.7 million, higher than the Zacks Consensus Estimate of $1,062 million.
Insider Trading Alert - TWX, CMS And BCR Traded By Insiders
at The Street - Wed Feb 19, 12:00PM CST
Stocks with insider trader activity include TWX, CMS and BCR
Why Endologix (ELGX) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:43AM CDT
It may be a good decision to sell Endologix as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a poor Zacks Rank confirms weakness.
Patterson Companies Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 5:15PM CDT
Patterson continues to face a challenging macro environment due to uncertainties surrounding the U.S. healthcare system as well as the ongoing austerity measures that have dampened demand for the past few years.
CR Bard Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:10AM CDT
Shares of BCR started escalating following optimism triggered by promising 2014 guidance.
Quest Diagnostics Ups View on Solstas Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 4:20PM CDT
With the declaration of the closure of its earlier announced acquisition of Solstas Lab Partners Group and its subsidiaries, Quest Diagnostics also raised its 2014 financial outlook.
DENTSPLY International Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:30PM CDT
Positive earnings guidance and anticipated improvement in the global market conditions in 2014, combined with improving leveraged position and margins, represent a potential upside for DENTSPLY going forward.
Watch for CR Bard to Potentially Pullback After Gaining 1.15% Yesterday
Comtex SmarTrend(R) - Mon Mar 10, 5:28PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $143.50 to a high of $145.86. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $145.55 on volume of 752,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CR Bard Rises 1.15% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Mar 10, 5:28PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $143.50 to a high of $145.86. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $145.55 on volume of 752,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Balanced View Continues for Henry Schein - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 1:50PM CDT
On Mar 07, 2014, we issued an updated research report on Henry Schein Inc.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cooper Companies Beats on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:32PM CST
For fiscal 2014, COO now expects total revenues between $ 1,685 and $1,725 million compared with the prior guidance of $1,675 and $1,735 million.
Financial Results Releases, Clinical Study Updates, Stock Summaries, and Strategic Agreements - Analyst Notes on Insmed, Medtronic, CR Bard, LabCorp, and Acceleron Pharma
PR Newswire - Fri Mar 07, 5:19AM CST
Today, Analysts Review released its analysts' notes regarding Insmed Incorporated (NASDAQ: INSM), Medtronic, Inc. (NYSE: MDT), CR Bard Inc. (NYSE: BCR), Laboratory Corp. of America Holdings (NYSE: LH), and Acceleron Pharma, Inc. (NASDAQ: XLRN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Bio-Reference Laboratories (BRLI) Falls: Stock Goes Down 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:42AM CST
Bio-Reference Laboratories saw a big move last session on pretty good volume with far more shares changing hands than in a normal session; shares fell over 5% on the day.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
Insider Trading Alert - BCR, ADS And PII Traded By Insiders
at The Street - Fri Feb 28, 9:45AM CST
Stocks with insider trader activity include BCR, ADS and PII
CR Bard Set to Possibly Pullback After Yesterday's Rally of 1.15%
Comtex SmarTrend(R) - Thu Feb 27, 5:08PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $142.68 to a high of $145.21. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $144.06 on volume of 824,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of CR Bard to Potentially Pullback after Yesterday's 1.15% Rise
Comtex SmarTrend(R) - Thu Feb 27, 5:07PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $142.68 to a high of $145.21. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $144.06 on volume of 824,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Insider Trading Alert - BCR, CBG And FANG Traded By Insiders
at The Street - Thu Feb 27, 9:45AM CST
Stocks with insider trader activity include BCR, CBG and FANG
Global Medical Electrodes Market Forecasts & Opportunities, 2018
M2 - Thu Feb 27, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/5hvqsv/global_medical) has announced the addition of the "Global Medical Electrodes Market Forecasts & Opportunities, 2018" report to their offering. Reusable electrodes present risks of cross contamination leading to hospital acquired infections. Commonly referred to as nosocomial infections, these infections affect about 1.7 million of the US population every year causing the death of roughly 99,000 people. Hence, medical device equipment employing electrodes needs to be replaced to avoid hospital acquired infections. Thus, the market is currently witnessing a shift toward increase in the use of disposable electrodes. These electrodes could be used for about a week or more before discarding them. They are cost effective and flexible for use in patients. This trend is in turn expected to drive the growth of the Global Medical Device Electrodes market. According to the report, one of the major drivers in this market is the increase in the aging population. The rising aging population is contributing toward an increase in usage of medical devices. This in turn is driving the growth of the Global Medical Device Electrodes market. Further, the report states that one of the main challenges in this market is pricing pressures. Fluctuations in the price of metals and by-products of petrol such as plastic could affect the price rate of the supplies within the supply chain. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Geographical Segmentation 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis - 3M Corp. - Ambu A/S - CR Bard Inc. - Covidien plc. - ConMED Corp. - Cardinal Health Inc. For more information visit http://www.researchandmarkets.com/research/5h...al_medical
Patterson Companies Q3 Meets Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:05AM CST
Revenues for the quarter grew 18.2% to $1,082.7 million, higher than the Zacks Consensus Estimate of $1,062 million.
Insider Trading Alert - TWX, CMS And BCR Traded By Insiders
at The Street - Wed Feb 19, 12:00PM CST
Stocks with insider trader activity include TWX, CMS and BCR
